Protecting against misuse without forfeiting the potential benefits is key
The global market for artificial intelligence (AI) for healthcare is booming. Currently valued at $15bn (£12bn; €14bn), it is expected to near $200bn by 2030.12 Public sector spending on AI for healthcare is also on the rise. The UK government, for example, has already invested more than £123m in AI for healthcare technologies.3 Of course, previous AI “summers” were followed swiftly by AI “winters,” when the gap between expectations and the reality of AI grew too wide. This summer’s heat and longevity can largely be attributed to the advent of generative AI.
Generative AI is a type of machine learning capable of generating data in a range of formats (including text, image, audio, video, or code) and adapting to new tasks in real time, following simple text based prompts. These capabilities make generative AI flexible, as one “model” (for example, ChatGPT or DALL-E) can be used for a variety o
New UK clinical trials legislation will prioritise transparency
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.
Commentary: Why the courts are right to rule against LinkedIn in battle over data scraping – GeekWire
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.